5th Annual New England Pharmacists Convention

October 1, 2009 through October 2, 2009

Mohegan Sun Resort
1 Mohegan Sun Blvd
Uncasville, CT 06382

View Convention fees: Display the current overall convention fees.
View CE Session listing: View and register for convention ce sessions.
View Presenter listing: Display all convention presenters.
View Convention schedule: Display current convention schedule and create a personalized itinerary.
Register for Convention

Online Registration is Now Closed
Walk-In Registration Only
Please Join Us!

Or, download: Registration Brochure for Pharmacists
Registration Brochure for Technicians

and fax your completed registration form to: 781-933-1109

or mail it to: MPhA, 500 West Cummings Park, Suite 3475
Wobrun, MA 01801

Students: Sign up for the Pain Counseling Competion and a chance to win $1,000!

Please Note: Registration for the MTM and Immunization Certificate Programs is now closed

Reserve your room at the special rate of $229
Call 1-888-777-7922 and use the Code NEPC09

Tentative Schedule

Thursday October 1st

7:30 a.m. - 8:00 a.m.
Certificate Program Registration

8:00 a.m. - 12:00 p.m.
Vaccinating Adults & Adolescents: An Immunization Program
Practicum Session Certificate Program

8:00 a.m. - 5:00 p.m.
Delievering Medication Therapy Management in the
Community Certificate Program

12:00 p.m. - 1:00 p.m.
Convention Check In & Walk In Registration

1:00 p.m. - 2:30 p.m.
Novel Approaches to Assessing and Managing Pain in the
Community Pharmacy Setting
Richard Gannon, PharmD, Clinical Specialist - Pain
Management Hartford Hospital, Hartford, CT
0.15 CEUs ACPE #106-999-09-014-L01-P
Upon completion of this program participants will be able to:
1. State the epidemiology and burden associated with
Under treatment of chronic pain;
2. Examine the evidence on new and current treatment
options for chronic pain management;
3. Identify barriers associated with pain therapies and
methods to overcome these barriers;
4. Review management strategies for chronic pain
considering clinical, economic and patient factors.
Activity Type: Knowledge Based
Supported by educational grants from Pricara & Purdue

2:45 p.m. - 3:45 p.m.

Update from the DEA: Your Questions Answered on

Controlled Substances (Law CE)

Mark W. Caverly, Chief, Liason & Policy Section for DEA,

Washington, DC

0.1 CEUs ACPE #106-999-09-016-L03-P

Upon completion of this program participants will be able to:

1. Explain the legality of e-prescribing controlled substances;

2. Identify trends in the implementation of prescription drug

monitoring programs;

3. Review regulatory issues regarding controlled substance

prescribing, dispensing and record keeping.

Activity Type: Knowledge Based

Supported by the Connecticut & Massachusetts

Pharmacists Associations

3:45 p.m. - 5:15 p.m.

Assessing the Role of New and Emerging Therapies

in Diabetes Management

Lisa Cohen, PharmD, CDE, Assistant Professor Dept of

Pharmacy Practice, University of Rhode Island School of

Pharmacy

0.15 CEUs ACPE #106-999-09-015-L01-P

Upon completion of this program participants will be able to:

1. Define the role of the newer and emerging treatments for

diabetes in the scope of the new ADA Guidelines as well as

achieving optimal patient care;

2. Assess the placement of the new and emerging agents in

the continuum of care in the patient with diabetes;

3. Recap the role of the pharmacist in the selection and

monitoring.

Activity Type: Knowledge Based

Supported by an educational grant from Daiichi Sankyo

5:30 p.m. - 6:00 p.m.

CPA & MPhA Business Meeting

6:30 p.m. - 7:30 p.m.

Cocktail Reception - Great networking opportunity!

7:30 p.m.- 9:30 p.m.
Annual Installation and Awards Banquet

Friday, October 2, 2009

6:00 a.m. - 8:00 a.m.

Check-In, Registration and Vendor Set-Up

6:30 a.m. - 8:00 a.m.

Breakfast Symposium: Open to the first 200 attendees!

Applying Medication Therapy Management to Chronic

Obstructive Pulmonary Disease

Jake Nichols, Pharm.D., MBA, BCPS, Director of Clinical Affairs

Commonwealth Medicine/UMass Medical School

0.15 CEUs ACPE #106-999-09-017-L01-P

Upon completion of this program participants will be able to:

1. Compare and contrast the features that differentiate COPD and

asthma;

2. Outline management objectives and guidelines for COPD

treatment;

3. Review current evidence and use of COPD medication regimens;

4. Discuss lifestyle strategies pharmacists can recommend to their

patients to better manage the disease progression of COPD and

improve quality of life;

5. Discuss how medication therapy management can be applied to

COPD patients.

Activity Type: Knowledge Based

Supported by an educational grant from AstraZeneca

7:00 a.m. - 8 a.m.

CONTINENTAL BREAKFAST

8:15 a.m. - 10:15 a.m.

New England College ‘Pepto Bowl’

Student & Pharmacist Self-Care Championship

Facilitators: Jef Bratberg, PharmD URI College of Pharmacy

0.2 CEUs ACPE #106-999-09-018-L04-P

Upon completion of this program participants will be able to:

1. Identify products (and active ingredients) routinely used for safe

and effective use in self-care conditions

2. Explain the efficacy, dosage, adverse effects, and administration

of non-prescription medicines;

3. Counsel on non-pharmacologic measures for the treatment of

common self-care ailments.

Activity Type: Knowledge Based

Sponsored by New England Colleges and Universities

10:15 a.m. - 11:00 a.m.

Break - Sponsored by Northeastern University School of Pharmacy

11:00 a.m. - 12:00 p.m.

Counterfeit Pharmaceuticals: A Threat to Public Health

and Safety (Law CE)

Brian Donnelly, R.Ph., MS, Ph.D. Director, Global Security for

North America, Pfizer

0.1 CEUs ACPE #106-999-09-019-L03-P

Upon completion of this program participants will be able to:

1. Explain the scope of the problem with counterfeit drugs and their

threat to public health and safety;

2. Explain the risks associated with counterfeit medicines;

3. State where counterfeit drugs are made and how they get to the

consumer.

Activity Type: Knowledge Based

Supported by The University of Connecticut School of

Pharmacy Henry S. Johnson Memorial Lecture

11:15 a.m. - 12:30 p.m. Student Program

Successful Navigation through the Residency Pharmacy

Process

Teresa Seo, Pharm.D., Hospital of Saint Raphael,

New Haven, CT

A presentation for pharmacy students which will explain the

benefits of considering a residency after graduation.

12:00p.m.- 2:00 p.m.

LUNCH in the Exhibit Hall

EXHIBIT HALL OPEN

Concurrent Sessions Begin

2:00 p.m.-3:00 p.m.

Track I: Focus on Bipolar Disorder: The Pharmacist’s Role

Megan Ehret, Pharm D, BCPP, Assistant Professor, UConn,

Institute of Living, Hartford, CT

0.1 CEUs ACPE #106-999-09-020-L01-P

Upon completion of this program participants will be able to:

1. Review the acute and maintenance treatment for bipolar disorder;

2. Describe the lifestyle changes and pharmaceutical strategies

(including the modes of action, efficacy, and contraindications

of currently available therapies) available for managing bipolar

disorder;

3. Discuss the importance and impact of poor therapy adherence to

long-term maintenance treatment for bipolar disorder;

4. Assess the pharmacist’s role in counseling patients and their

caregivers on lifestyle changes and medication adherence to longterm

treatment of bipolar disorder.

Activity Type: Knowledge Based

Supported by an educational grant from AstraZeneca

Track II: Facing the Reality of Substance Abuse in

Healthcare

William Ward, R.Ph., MS, Consultant: Wardwebsites

0.1 CEUs ACPE #106-999-09-021-L04-P

Upon completion of this program participants will be able to:

1. Discuss the impact of alcohol and drug abuse by healthcare

professionals;

2. Recognize the physical, behavioral, and performance traits

commonly seen with substance abuse

3. Describe the complications related to the major classes of

commonly abused drugs

4. Explain how to address a healthcare professional or coworker

that demonstrates signs of substance abuse.

Activity Type: Knowledge Based

Supported by the Massachusetts Pharmacists Association

Foundation and the Connecticut Pharmacists Foundation.

Track III: Drug - Drug Interactions: Basic Concepts and

Clinical Implications for the Elderly

Dennis Chapron, R.Ph., MS, Medication Safety Offi cer, Pharmacy

Dept., St. Francis Hospital, Hartford, CT

0.1 CEUs ACPE #106-999-09-027-L04-P

Upon completion of this program participants will be able to:

1. Describe some common drug interactions that compromise

the bioavailability of quinolone antibiotics, tetracyclines and

levothyroxine;

2. Organize the Cytochrome p-450 drug metabolizing enzymes

according to substrates, inducers and inhibitors;

3. Explain the involvement of p-glycoprotein in drug transport and

drug interactions;

4. List three pharmacodynamic interactions that result in

augmented pharmacologic effects.

Activity Type: Knowledge Based

Supported by the Connecticut & Massachusetts Pharmacists

Associations

3:15 p.m. - 4:15 p.m.

Track I: Update on HIV: Review of Antiretroviral

Treatment Options and the Role of the Pharmacist

Joel L. Zive,ParmD, C.F.,FACA, Zive Pharmacy & Surgical Inc,

Bronx, NY

0.1 CEUs ACPE #106-999-09-022-L01-P

Upon completion of this program participants will be able to:

1. Identify antiretroviral drug targets for HIV;

2. Review the current and new classes of antiretroviral medications;

3. Discuss the efficacy and safety associated with each class of

antiretroviral medication;

4. Communicate important information such as storage, special

dosing populations, food requirements, and drug- interactions to

physicians and patients.

Activity Type: Knowledge Based

Supported by CPA & MPhA

Track II: Grasping the Phases and Treatment Approaches of

Schizophrenia

Charles F. Caley, PharmD, BCPP, Associate Clinical Professor, UConn,

Burlingame Research Center, Institute of Living, Hartford, CT

0.1 CEUs ACPE #106-999-09-024-L01-P

Upon completion of this program participants will be able to:

1. Identify the phases of schizophrenia;

2. Compare and contrast the treatment approaches for each phase of

schizophrenia;

3. Examine the evidence surrounding individualized treatment plans that

improve adherence and outcomes for patients with schizophrenia;

4. Cultivate a multidisciplinary team approach to improve treatment

adherence in patients with schizophrenia.

Activity type: Knowledge Based

Supported by an educational grant from AstraZeneca

Track III: New Insights into Pathophysiology, and Treatment of

Type 1 Diabetes in Children

Don Zettervall, R.Ph., CDE, Owner, Diabetes Center Old Saybrook,CT

0.1 CEUs ACPE#106-999-09-023-L01-P

Upon completion of this program participants will be able to:

1. Summarize the pathophysiology of type 1 diabetes;

2. Identify characteristics of intensive type 1 diabetes management;

3. Recognize current research approaches to prevent or cure type 1

diabetes.

Activity Type: Knowledge Based

Supported by an educational grant from Novo Nordisk

4:30 p.m. - 5:30 p.m.

Track I: Improving Medication Safety in Community Pharmacy:

Assessing Risk and Opportunities for Change

Donna Horn, RPh, DPh, Director Patient Safety, Community Practice,

ISMP, Horsham, PA

0.1 CEUs ACPE #106-999-09-026-L05-P

Upon completion of this program participants will be able to:

1. Examine flow diagrams of the medication process to identify

variability in current medication-use processes;

2. Select effective error reduction strategies that can prevent patient harm;

3. Review case scenario(s) of medication error or near miss events and

apply knowledge of ISMP’s Key Elements to identify breakdowns in the

system that have contributed to the error;

4. Utilize the Assess-ERR (tm) Medication Error Worksheet.

Activity Type: Knowledge Based

Supported by an educational grant from CPA & MPhA

Track II: Update in Anticoagulation Management

0.1 CEUs ACPE #106-999-09-025-L01-P

Karen Fiumara, Pharm.D., Medication Safety Officer, Manager

Anticoagulation Mgt., Brigham & Women’s Hosp. Boston, MA

Upon completion of this program participants will be able to:

1. Identify VTE epidemiology, risk factors and treatment options;

2. Discuss the importance of VTE prophylaxis;

3. Discuss novel anticoagulants.

Activity Type: Knowledge Based

Supported by an educational grant from Ortho-McNeil Janssen

Scientific Affairs, LLC

Track III: Pediatric Dosing: Not as scary as it seems

Margaret M. Burke, Pharm.D., Pediatric Clinical Specialist,

Connecticut Children’s Medical Center, Hartford, CT

0.1 CEUs ACPE #106-999-09-028-L04-P

Upon completion of this program participants will be able to:

1.Describe pharmacokinetics and pharmacodynamics in the pediatric

population;

2. Discuss the differences in dosing between pediatric and adult

population;

3. Identify resources available to assist in determining pediatric dosing;

4. Discuss pediatric focused clinical trials.

Activity Type: Knowledge Based

Supported by an educational grant from CPA & MPhA